Wider Perspectives Limited is an independent company providing exceptional, value-added, risk-based, regulatory compliance quality management consulting services, around the world. We have supported the successful registration of multiple pharmaceutical products by enabling sponsors to clear the hurdle of regulatory authority inspections. We were privileged to be involved in the inspection readiness preparations that resulted in CHMP approval of the Western World's first gene therapy product. With a combined total of over 50 years’ experience of pharmaceutical development, the two principals of Wider Perspectives have assisted customers, vendors and auditees in over 45 countries to “see the whole picture”, thereby enabling all parties to put their roles into context. The GCP experience of our principals covers First-in-Human studies through product registration into post-marketing surveillance and spans a wide variety of therapeutic areas. Across the full range of our services our principals are fully hands-on in assuring high quality customer service and deliverables throughout the lifetime of your project. Our services include expert GCP advice, quality assurance, risk assessment, quality management, clinical development, strategic and tactical planning, project management and audit.